4.7 Article

Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 200, Issue 1, Pages 115-122

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20040612

Keywords

autoimmunity; antibody secretion; cellular differentiation; immunoglobulin; IRF-4

Funding

  1. NIAID NIH HHS [AI01803, AI057471, R01 AI057471] Funding Source: Medline
  2. NIDDK NIH HHS [DK52574, P30 DK052574] Funding Source: Medline

Ask authors/readers for more resources

B cell terminal differentiation involves development into an antibody-secreting plasma cell, reflecting the concerted activation of proplasma cell transcriptional regulators, such as Blimp-1, IRF-4, and Xbp-1. Here, we show that the microphthalmia-associated transcription factor (MitF) is highly expressed in naive B cells, where it antagonizes the process of terminal differentiation through the repression of IRF-4. Defective Mitf activity results in spontaneous B cell activation, antibody secretion, and autoantibody production. Conversely, ectopic Mitf expression suppresses the expression of IRF-4, the plasma cell marker CD138, and antibody secretion. Thus, Mitf regulates B cell homeostasis by suppressing the antibody-secreting fate.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available